These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36528754)

  • 1. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.
    Liu W; Ji J; Zou D; Cao Y; Xu Y; Zhou J; Gao S; Wang F; Chen W; Du J; Zhou H; Zhou F; Shi J; Zhang X; Yang J; Jing H; Jiang Z; Liu H; Li C; Peng H; Jiang S; Wei X; He P; Liu Y; Yang H; Li Z; Huang X; Liu L; Shen L; Liu C; Song Y; Qiu L; Wang X; Ma J; Zhu J
    Bone Marrow Transplant; 2023 Mar; 58(3):349-352. PubMed ID: 36528754
    [No Abstract]   [Full Text] [Related]  

  • 2. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
    Ali N; Adil SN; Shaikh MU
    Stem Cells Transl Med; 2015 Aug; 4(8):873-7. PubMed ID: 26032748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients.
    Noiperm P; Julamanee J; Viboonjuntra P; Lekhakula A
    Ann Transplant; 2023 Jan; 28():e938595. PubMed ID: 36647325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.
    Hartmann T; Hübel K; Monsef I; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010615. PubMed ID: 26484982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
    Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
    BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.
    Hansen PB; Penkowa M
    Support Care Cancer; 2017 Apr; 25(4):1279-1289. PubMed ID: 27966023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem-cell transplantation in multiple myeloma.
    Gahrton G
    Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
    Tekgündüz E; Arat M; Göker H; Özdoğu H; Kaynar L; Çağırgan S; Erkurt MA; Vural F; Kiki İ; Altuntaş F; Demirkan F;
    Transfus Apher Sci; 2017 Dec; 56(6):845-849. PubMed ID: 29153306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.
    Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas.
    Batorov EV; Shevela EY; Tikhonova MA; Batorova DS; Ushakova GY; Sizikova SA; Sergeevicheva VV; Gilevich AV; Kryuchkova IV; Ostanin AA; Chernykh ER
    Cell Immunol; 2015 Oct; 297(2):80-6. PubMed ID: 26227214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
    Crocchiolo R; Chabannon C; El-Cheikh J; Esterni B; Lemarié C; Fürst S; Castagna L; Bouabdallah R; Ladaique P; Coso D; Schiano JM; Stoppa AM; Rey J; Ivanov V; Aurran T; Faucher C; Blaise D; Calmels B
    Leuk Lymphoma; 2013 Feb; 54(2):417-20. PubMed ID: 22702654
    [No Abstract]   [Full Text] [Related]  

  • 13. Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
    Mangan PA; Gleason CL; Miceli T
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():43-7. PubMed ID: 24280458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
    Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-cerebral relapse following prolonged remission after autologous stem cell transplantation for multiple myeloma.
    Seftel MD; Maguire J; Voss N; Woodhurst WB; Dalal BI; Shepherd JD
    Leuk Lymphoma; 2002 Dec; 43(12):2399-403. PubMed ID: 12613531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.
    Cogbill CH; Drobyski WR; Komorowski RA
    Mod Pathol; 2011 Jan; 24(1):117-25. PubMed ID: 20953169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation in multiple myeloma.
    Bladé J
    Haematologica; 2006 Sep; 91(9):1157. PubMed ID: 16956811
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
    Deauna-Limayo D; Aljitawi OS; Ganguly S; Abhyankar S; Wick JA; McGuirk JP
    J Oncol Pharm Pract; 2014 Aug; 20(4):263-9. PubMed ID: 24005093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous hematopoietic stem cell grafts - moving away from a one-size-fits-all approach.
    Melve GK; Sandnes M; Reikvam H
    Expert Rev Hematol; 2022 Jan; 15(1):1-4. PubMed ID: 34949139
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
    Salvini M; Maggi F; Damonte C; Mortara L; Bruno A; Mora B; Brociner M; Mattarucchi R; Ingrassia A; Sirocchi D; Bianchi B; Agnoli S; Gallazzi M; Merli M; Ferrario A; Bombelli R; Barraco D; Baj A; Bertù L; Grossi PA; Passamonti F
    Bone Marrow Transplant; 2022 Jan; 57(1):137-139. PubMed ID: 34635796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.